BioSpace News Archive

Nevro to Host Conference Call on Thursday, August 2, 2018 at 1:30 p.m. PT / 4:30 p.m. ET

Invacare Corporation today announced the appointment of Diana S. Ferguson, to its Board of Directors, effective July 19, 2018.

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced plans today to create a National Center of Excellence for Eating Disorders, focused on developing and disseminating eating disorder training and technical assistance for healthcare practitioners through a grant of up to $3.75 million awarded to a non-profit agency or university.

Omnicell, Inc. will hold a conference call on Thursday, July 26, 2018 to discuss the Company’s Second Quarter 2018 financial results.

Accuray Inc.(NASDAQ: ARAY) announced today the appointment of Joseph E. Whitters to the company’s Board of Directors, effective as of July 16, 2018. In addition, he will serve on the Board’s Audit Committee. With Mr. Whitters’ appointment, the Accuray Board has been expanded to eight members.

Hill-Rom Holdings, Inc. is changing the start time of its fiscal third quarter 2018 earnings conference call and webcast on Friday, July 27, 2018, to 7:00 a.m. (CT) / 8:00 a.m. (ET).

Provention Bio, Inc. (Nasdaq:PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced today the closing of its initial public offering of shares of its common stock at a public offering price of $4.00 per share on July 19, 2018.

Universal Health Services, Inc. announced that its Board of Directors voted to pay a cash dividend of $0.10 per share on September 17, 2018 to shareholders of record as of September 4, 2018.

Catalent, Inc. announced that it will release financial results for the fourth quarter of fiscal year 2018 ended June 30, 2018, before the market open on Tuesday, August 28, 2018.